Regulatorische Updates

Regulatorische Entwicklungen von FDA, EMA, TGA und weltweit

#Claudin18.2 ×

Regulatorische Updates

30. Aug. 2026•1 Min. Lesezeit

Claudin18.2‑Targeted CAR‑T Therapy Achieves First Global Approval for Solid Tumor

Claudin18.2‑targeted CAR‑T therapy is the first CAR‑T to receive global approval for a solid tumor.